Object's details: HUMAN GENETIC DISORDERS PART 2 – DIAGNOSIS AND TREATMENT

Provider:Repozytorium Instytutu Biochemii i Biofizyki Polskiej Akademii Nauk

Description

Title:
HUMAN GENETIC DISORDERS PART 2 – DIAGNOSIS AND TREATMENT
Creator:
Gabig-Cimińska, Magdalena;
Kloska, Anna;
Malinowska, Marcelina
Description:
The first genetic test was run in 1978 by Kan and Dozy and independently by Orkin et al. The molecular testing was performed to detect the mutation c.20A>T in the β-globin DNA responsible for sickle cell anaemia. Kan and Dozy applied restriction analysis of the β-globin gene followed by hybridisation with a molecular probe complementary to the fragment of human β-globin sequence (RFLP method) [1]. Results enabled them the discrimination between mutant homozygotes (affected persons), normal homozygotes (healthy persons) and heterozygotes (mutation carriers). To detect the same mutation, Orkin et al. applied hybridisation with two variant oligonucleotide molecular probes to distinguish between mutant and normal alleles of the β-globin gene [2]. A milestone in development of molecular diagnostic techniques for detection of human mutations was the invention of polymerase chain reaction (PCR) made in 1983 by Kary Mullis. The PCR in molecular diagnostics is generally used to amplify DNA fragment before other molecular analyses are performed. Genetic testing is divided in two categories: direct testing and indirect testing (gene tracking). Direct genetic testing involves testing for a certain genotype, i.e. identification of a specific pathogenic mutation within a gene, that is responsible for a certain condition. Indirect genetic testing also known as gene tracking tests the inheritance and segregation of genetic markers linked to a specific condition within a family.
Object availability:
free access
Date:
2013
Type:
Monograph;
NonPeerReviewed
Language:
English;
eng
Format:
application/pdf
Publisher:
Uniwersytet Gdański
Relation: http://eprints.ibb.waw.pl/1126
Subject:
Q Science (General);
R Medicine (General);
RM Therapeutics. Pharmacology
Identifier: http://eprints.ibb.waw.pl/1126/1/skrypt_HGD-part2.pdf ;
Gabig-Cimińska, Magdalena and Kloska, Anna and Malinowska, Marcelina (2013) HUMAN GENETIC DISORDERS PART 2 – DIAGNOSIS AND TREATMENT. Discussion Paper. Uniwersytet Gdański.
Data provider:
Repozytorium Instytutu Biochemii i Biofizyki Polskiej Akademii Nauk

Similar objects

HUMAN GENETIC DISORDERS PART 2 – DIAGNOSIS AND TREATMENT

Creator:Gabig-Cimińska, Magdalena | Kloska, Anna | Malinowska, Marcelina

Date:2013

Type:other

Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases

Date:2013

Type:other

Evaluation of Anti-cancer Activity of Stilbene and Methoxydibenzo[b,f] oxepin Derivatives

Date:2017

Type:other

Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice

Date:2022.04.12

Type:other

Interindividual variability of atorvastatin treatment influence on the MPO gene expression in patients after acute myocardial infarction

Date:2016

Type:other

Cellular and gene expression response to the combination of genistein and kaempferol in the treatment of mucopolysaccharidosis type I

Date:2022

Type:other

Use of cytokine mix-, imiquimod-, and serum-induced monoculture and lipopolysaccharide- and interferon gamma-treated co-culture to establish in vitro psoriasis-like inflammation models

Creator:Bocheńska, Katarzyna | Moskot, Marta | Gabig-Cimińska, Magdalena

Date:2021

Type:other

Impact of isoflavone genistein on psoriasis in in vivo and in vitro investigations

Date:2021

Type:other

Federacja Bibliotek Cyfrowych

Object's details: HUMAN GENETIC DISORDERS PART 2 – DIAGNOSIS AND TREATMENT

Description

Similar objects